Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

BioLineRx Ltd

BLRX
Current price
0.72 USD +0.024 USD (+3.48%)
Last closed 0.69 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 56 328 648 USD
Yield for 12 month -54.20 %
1Y
3Y
5Y
10Y
15Y
BLRX
21.11.2021 - 28.11.2021

BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It also develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel. Address: Modi?in Technology Park, Hevel Modi'in, Israel, 7177871

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

13.75 USD

P/E ratio

Dividend Yield

Current Year

+4 800 000 USD

Last Year

Current Quarter

+4 800 000 USD

Last Quarter

Current Year

+174 000 USD

Last Year

-654 000 USD

Current Quarter

+1 108 000 USD

Last Quarter

-221 000 USD

Key Figures BLRX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -42 172 000 USD
Operating Margin TTM -247.15 %
PE Ratio
Return On Assets TTM -38.3 %
PEG Ratio 0.2
Return On Equity TTM -189.23 %
Wall Street Target Price 13.75 USD
Revenue TTM 4 800 000 USD
Book Value 0.012 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -0.9 USD
Diluted Eps TTM -0.9 USD
Most Recent Quarter IV 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics BLRX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History BLRX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:15
Payout Ratio
Last Split Date 15.07.2019
Dividend Date 15.07.2019

Stock Valuation BLRX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 5.2922
Price Sales TTM 11.9376
Enterprise Value EBITDA -0.445
Price Book MRQ 4.3334

Financials BLRX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators BLRX

For 52 weeks

0.55 USD 2.53 USD
50 Day MA 0.78 USD
Shares Short Prior Month 410 593
200 Day MA 1.32 USD
Short Ratio 0.68
Shares Short 219 066
Short Percent 0.45 %

Dynamics of changes in the value of assets

Stocks


MSFT

MSFT

430.32 USD Microsoft Corporation +0.69 (+0.16%)
Detailed analytics

ETF funds


S

SX7EEX

14.75 EUR iShares EURO STOXX Banks 30-15 UCITS ETF (DE) 0 (0%)
Detailed analytics

Metals


Gold

2357.98 USD Gold +6.23 (+0.27%)
Detailed analytics